It is a research & development private limited company based in Delhi, Delhi, India, established in 2022.
2022 | Delhi, Delhi, India | ActiveOnco-Vac Biopharma Private Limited, a active private limited company, was established on 16 September 2022 in Delhi, Delhi, India. Engaging in science research within the research & development sector, it holds CIN: U73100DL2022PTC404697. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Raj Kumar Mallick (Director), Ashok Kumar Vaid (Director), Ram Vishwakarma Asrey (Director). Its latest AGM occurred on 03 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-3/53 T/F, Janakpuri, Delhi, Delhi, 110058.
U73100DL2022PTC404697
404697
16 September 2022
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Onco-Vac Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raj Kumar Mallick | Director | 16 Sep 2022 | Current |
| Ashok Kumar Vaid | Director | 16 Sep 2022 | Current |
| Ram Vishwakarma Asrey | Director | 10 Feb 2023 | Current |
| Anant Vishwakarma | Director | 14 Nov 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Onco-Vac Biopharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Onco-Vac Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Onco-Vac Biopharma has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Onco-Vac Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onco-Vac Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Onco-Vac Biopharma Private Limited last Annual general meeting of members was held on 03 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Onco-Vac Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Ram Vishwakarma Asrey was appointed as a Director was appointed as a Director on 10 Feb 2023 & has been associated with this company since 2 years 9 months . was documented.
The activity Anant Vishwakarma was appointed as a Director was appointed as a Director on 14 Nov 2022 & has been associated with this company since 3 years 20 days . was completed.
Progress on Raj Kumar Mallick was appointed as a Director was appointed as a Director on 16 Sep 2022 & has been associated with this company since 3 years 2 months . was documented.
Progress on Ashok Kumar Vaid was appointed as a Director was appointed as a Director on 16 Sep 2022 & has been associated with this company since 3 years 2 months . was documented.
The CIN of Onco-Vac Biopharma Private Limited is U73100DL2022PTC404697.
Onco-Vac Biopharma Private Limited is headquartered at B-3/53 T/F, Janakpuri, Delhi, Delhi, 110058.
Onco-Vac Biopharma Private Limited was incorporated on 16 September 2022.
The current directors of Onco-Vac Biopharma Private Limited are
The primary industry of Onco-Vac Biopharma Private Limited is Research & Development.
Onco-Vac Biopharma Private Limited is unlisted.
The authorized capital of Onco-Vac Biopharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX